The Trend in Morning Levels of Salivary Cortisol in Children With ADHD During 6 Months of Methylphenidate Treatment

Abstract

Objective: To determine the trend in cortisol levels in children with ADHD treated with methylphenidate (MPH) and nontreated healthy controls over a 6-month period. Method: The morning salivary cortisol levels of 50 patients with ADHD (40 boys and 10 girls, mean age = 7.6 years) and 50 age- and gender-matched healthy controls were measured at baseline and at 1, 3, and 6 months from baseline. The neuropsychological performance of the ADHD patients was measured via administration of the Continuous Performance Test. Results: The cortisol levels of ADHD patients increased significantly after 1 month of MPH treatment before decreasing to an intermediate level, but were significantly positively correlated with neuropsychological performance throughout the 6-month treatment period. The cortisol levels of the controls did not change significantly over the 6-month period. Conclusion: MPH administration appears to positively influence the functioning of the hypothalamic–pituitary–adrenal axis in ADHD patients.

Keywords

ADHD methylphenidate cognitive function psychostimulant neurobiology

Get full access to this article

View all access options for this article.

References

Achenbach

T. M.

(1991). Manual for the revised Child Behavior Checklist. Burlington: Department of Psychiatry, University of Vermont.

Alink

L. R.

van Ijzendoorn

M. H.

Bakermans-Kranenburg

M. J.

Mesman

Juffer

Koot

H. M.

(2008). Cortisol and externalizing behavior in children and adolescents: Mixed meta-analytic evidence for the inverse relation of basal cortisol and cortisol reactivity with externalizing behavior. Developmental Psychobiology, 50, 427-450.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

Biederman

Monuteaux

M. C.

Kendrick

Klein

K. L.

Faraone

S. V.

(2005). The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Archives of Disease in Childhood, 90, 1010-1015.

Blomqvist

Holmberg

Lindblad

Fernell

Dahllof

(2007). Salivary cortisol levels and dental anxiety in children with attention deficit hyperactivity disorder. European Journal of Oral Sciences, 115, 1-6.

Bussing

Fernandez

Harwood

Wei

Garvan

C. W.

Eyberg

S. M.

Swanson

J. M.

(2008). Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: Psychometric properties and normative ratings from a school district sample. Assessment, 15, 317-328.

Conners

C. K.

(1985). The computerized Continuous Performance Test. Psychopharmacology Bulletin, 21, 891-892.

Conners

C. K.

(2004). Conners’ Continuous Performance Test II (CPTII) for Windows technical guide and software manual. New York, NY: MHS.

10.

Freitag

C. M.

Hanig

Palmason

Meyer

Wust

Seitz

(2009). Cortisol awakening response in healthy children and children with ADHD: Impact of comorbid disorders and psychosocial risk factors. Psychoneuroendocrinology, 34, 1019-1028.

11.

Gau

S. F.

Soong

W. T.

(1999). Psychiatric comorbidity of adolescents with sleep terrors or sleepwalking: A case-control study. Australian and New Zealand Journal of Psychiatry, 33, 734-739.

12.

Hellhammer

D. H.

Wust

Kudielka

B. M.

(2009). Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, 34, 163-171.

13.

Hibel

L. C.

Granger

D. A.

Cicchetti

Rogosch

(2007). Salivary biomarker levels and diurnal variation: Associations with medications prescribed to control children’s problem behavior. Child Development, 78, 927-937.

14.

Hong

H. J.

Shin

D. W.

Lee

E. H.

Y. H.

Noh

K. S.

(2003). Hypothalamic–pituitary–adrenal reactivity in boys with attention deficit hyperactivity disorder. Yonsei Medical Journal, 44, 608-614.

15.

Innovation Beyond Limits. (2007). Enzyme immunoassay for the in-vitro diagnostic quantitative determination of free cortisol in human saliva and of total cortisol in diluted serum. Hamburg, Germany: Gesellschaft Fur Immunchemie Und Immunbiologie.

16.

Jennrich

R. I.

Schluchter

M. D.

(1986). Unbalanced repeated-measures models with structured covariance matrices. Biometrics, 42, 805-820.

17.

Joyce

P. R.

Donald

R. A.

Nicholls

M. G.

Livesey

J. H.

Abbott

R. M.

(1986). Endocrine and behavioral responses to methylphenidate in normal subjects. Biological Psychiatry, 21, 1015-1023.

18.

Kariyawasam

S. H.

Zaw

Handley

S. L.

(2002). Reduced salivary cortisol in children with comorbid attention deficit hyperactivity disorder and oppositional defiant disorder. Neuroendocrinology Letters, 23, 45-48.

19.

Kaufman

Birmaher

Brent

Rao

Flynn

Moreci

Ryan

(1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 980-988.

20.

King

J. A.

Barkley

R. A.

Barrett

(1998). Attention-deficit hyperactivity disorder and the stress response. Biological Psychiatry, 44, 72-74.

21.

Lee

M. S.

Yang

J. W.

Y. H.

Han

Kim

S. H.

Lee

M. S.

Jung

I. K.

(2008). Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder. Child Psychiatry & Human Development, 39, 201-209.

22.

Lee

S. H.

Shin

D. W.

Stein

M. A.

(2010). Increased cortisol after stress is associated with variability in response time in ADHD children. Yonsei Medical Journal, 51, 206-211.

23.

Leung

P. W.

Kwong

S. L.

Tang

C. P.

T. P.

Hung

S. F.

Lee

C. C.

Liu

W. S.

(2006). Test-retest reliability and criterion validity of the Chinese version of CBCL, TRF, and YSR. Journal of Child Psychology and Psychiatry, 47, 970-973.

24.

Liu

Y. C.

Liu

S. K.

Shang

C. Y.

Lin

C. H.

C. L.

Gau

S. F.

(2006). Norm of the Chinese version of the Swanson, Nolan and Pelham, Version IV Scale for ADHD. Taiwanese Journal of Psychiatry, 20, 290-304.

25.

Lurie

O’Quinn

(1991). Neuroendocrine responses to methylphenidate and d-amphetamine: Applications to attention-deficit disorder. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 41-50.

26.

Chen

Y. H.

Chen

Liu

Y. Y.

Wang

Y. X.

(2011). The function of hypothalamus-pituitary-adrenal axis in children with ADHD. Brain Research, 1368, 159-162.

27.

Pesonen

A. K.

Kajantie

Jones

Pyhala

Lahti

Heinonen

Raikkonen

(2011). Symptoms of attention deficit hyperactivity disorder in children are associated with cortisol responses to psychosocial stress but not with daily cortisol levels. Journal of Psychiatric Research, 45, 1471-1476.

28.

Reynolds

Lane

S. J.

Gennings

(2010). The moderating role of sensory overresponsivity in HPA activity: A pilot study with children diagnosed with ADHD. Journal of Attention Disorders, 13, 468-478.

29.

Stadler

Kroeger

Weyers

Grasmann

Horschinek

Freitag

Clement

H. W.

(2011). Cortisol reactivity in boys with attention-deficit/hyperactivity disorder and disruptive behavior problems: The impact of callous unemotional traits. Psychiatry Research, 187, 204-209.

30.

Strous

R. D.

Spivak

Yoran-Hegesh

Maayan

Averbuch

Kotler

Weizman

(2001). Analysis of neurosteroid levels in attention deficit hyperactivity disorder. International Journal of Neuropsychopharmacology, 4, 259-264.

31.

Swanson

Gupta

Guinta

Flynn

Agler

Lerner

Wigal

(1999). Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clinical Pharmacology & Therapeutics, 66, 295-305.

32.

Talge

N. M.

Neal

Glover

(2007). Antenatal maternal stress and long-term effects on child neurodevelopment: How and why? Journal of Child Psychology and Psychiatry, 48, 245-261.

33.

van de Wiel

N. M.

van Goozen

S. H.

Matthys

Snoek

van Engeland

(2004). Cortisol and treatment effect in children with disruptive behavior disorders: A preliminary study. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 1011-1018.

34.

Wang

L. J.

Huang

Y. S.

Hsiao

C. C.

Chiang

Y. L.

C. C.

Shang

Z. Y.

Chen

C. K.

(2011). Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder. World Journal of Biological Psychiatry, 12, 99-109.

35.

Weizman

Dick

Gil-Ad

Weitz

Tyano

Laron

(1987). Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity. Life Science, 40, 2247-2252.

36.

Wilens

T. E.

(2008). Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 28, S46-S53.

37.

Yang

S. J.

Shin

D. W.

Noh

K. S.

Stein

M. A.

(2007). Cortisol is inversely correlated with aggression for those boys with attention deficit hyperactivity disorder who retain their reactivity to stress. Psychiatry Research, 153, 55-60.

38.

Young

Sweeting

West

(2011). Associations between DSM-IV diagnosis, psychiatric symptoms and morning cortisol levels in a community sample of adolescents. Social Psychiatry & Psychiatric Epidemiology, 47, 723-733.

39.

Zhang

Faries

D. E.

Vowles

Michelson

(2005). ADHD Rating Scale IV: Psychometric properties from a multinational study as a clinician-administered instrument. International Journal of Methods in Psychiatric Research, 14, 186-201.